Pfizer Inc. Teams With India Brewmaster in Return to $14 Billion Insulin Market

Bloomberg -- Biocon Ltd. founder Kiran Mazumdar- Shaw learned the intricacies of enzymes while studying how to make beer. Now Pfizer Inc., the world’s largest drugmaker, is tapping that knowledge to revive its insulin business.

MORE ON THIS TOPIC